Observational studyMicrobiology spectrum2025
Bacterial gastroenteritis in the world of culture-independent diagnostic testing: a study to evaluate the kinetics of bacterial shedding by culture and CIDT.
Observational study in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Repeat multiplex PCR gastrointestinal panel testing within 14 days yields minimal additional diagnostic information: a multicenter cohort study.Infection control and hospital epidemiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Reliable microbiological diagnosis is important for patient and public health management of bacterial gastroenteritis. Clinical laboratories are adopting culture-independent diagnostic tests (CIDT) widely. We examined the kinetics of bacterial shedding by CIDT and culture following an episode of acute gastroenteritis with one of three prevalent pathogens. The primary outcome was the proportion of samples that tested CIDT-positive or culture-positive at defined time intervals after clinical diagnosis. This longitudinal observational study was conducted in Calgary Health Zone (Alberta, Canada) between 2019 and 2022. Eligible adult patients (≥18 years) were consented and enrolled after a routine public health investigation. Stool samples were submitted at weeks 2, 3, 4, 5, and 6 post-diagnosis. Stools were tested using the commercial nucleic acid-based BD MAX Enteric Bacterial Panel (CIDT method) and routine culture methods. Thirty-seven of 83 enrolled individuals (45%) submitted at least one additional stool. Diagnostic specimens were positive for
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.